2026 · 1st Quarter (Jan 1 - Mar 31)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by RADIUS ADVOCACY, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 18, 2026
Income: $30,000.00
Expenses: Not reported
Registrant: RADIUS ADVOCACY, LLC
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filing UUID: e8560fe8-32e3-4b4e-8fc9-5eb9ab1252bc
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

CPT · Copyright/Patent/Trademark

Patent rights. Merchant rights.

PHA · Pharmacy

Issues related to competition pracitces in the pharmaceutical marketplace. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act.

Literal federal measure citations: S.1040, S.1041

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.